1. Home
  2. CLBT vs TMDX Comparison

CLBT vs TMDX Comparison

Compare CLBT & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cellebrite DI Ltd.

CLBT

Cellebrite DI Ltd.

HOLD

Current Price

$13.71

Market Cap

3.5B

Sector

Technology

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$112.82

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLBT
TMDX
Founded
1999
1998
Country
Israel
United States
Employees
1285
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.4B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CLBT
TMDX
Price
$13.71
$112.82
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$22.50
$148.22
AVG Volume (30 Days)
1.8M
835.2K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
382.18
EPS
N/A
4.87
Revenue
N/A
$605,494,000.00
Revenue This Year
$21.45
$24.25
Revenue Next Year
$17.47
$18.75
P/E Ratio
$45.29
$23.12
Revenue Growth
N/A
37.13
52 Week Low
$11.03
$88.50
52 Week High
$20.53
$156.00

Technical Indicators

Market Signals
Indicator
CLBT
TMDX
Relative Strength Index (RSI) 52.47 49.21
Support Level $13.01 $109.38
Resistance Level $15.09 $131.86
Average True Range (ATR) 0.68 5.21
MACD 0.10 1.79
Stochastic Oscillator 70.71 68.59

Price Performance

Historical Comparison
CLBT
TMDX

About CLBT Cellebrite DI Ltd.

Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: